Medicare Enrolled
Dr. Sabu Varghese, MD
Internal Medicine · New Hyde Park, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Varghese from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Varghese?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Varghese
Dr. Sabu Varghese is an internal medicine specialist in New Hyde Park, NY, with 12 years of NPI registration. Based on federal Medicare data, Dr. Varghese performed 3,553 Medicare services across 1,769 unique beneficiaries.
Between the years covered by Open Payments, Dr. Varghese received a total of $13,392 from 51 pharmaceutical and/or device companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Varghese is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 9% volume in NY
$13,392 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,553
Medicare services
Top 9% in NY for internal medicine
1,769
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~296 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
892 | $105 | $275 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
794 | $48 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
613 | $77 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
434 | $8 | $25 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
248 | $47 | $225 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
184 | $144 | $200 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
155 | $13 | $92 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
43 | $36 | $50 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 42 | $20 | $60 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
33 | $100 | $331 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
31 | $184 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $116 | $350 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
25 | $75 | $300 |
| Chronic care management, first 30 minutes This service covers the initial 30 minutes of care coordination for patients with two or more chronic conditions. It is provided personally by a healthcare professional each calendar month. |
15 | $26 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $67 | $212 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,392
Total received (2018-2024)
Avg $1,913/year across 7 years
Top 7% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
698
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,392 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,501
2023
$3,034
2022
$2,172
2021
$1,471
2020
$833
2019
$1,009
2018
$372
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$698
ABBVIE INC.
$467
Amgen Inc.
$426
Lilly USA, LLC
$339
Novo Nordisk Inc
$306
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$247
GlaxoSmithKline, LLC.
$190
SCILEX PHARMACEUTICALS INC.
$185
Otsuka America Pharmaceutical, Inc.
$178
Abbott Laboratories
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$131
Bayer Healthcare Pharmaceuticals Inc.
$121
Ardelyx, Inc.
$104
Lundbeck LLC
$97
Exact Sciences Corporation
$90
Astellas Pharma US Inc
$83
Corcept Therapeutics
$81
Amneal Pharmaceuticals LLC
$76
Esperion Therapeutics, Inc.
$73
PFIZER INC.
$66
E.R. Squibb & Sons, L.L.C.
$57
MEDICOMP INC
$56
Janssen Pharmaceuticals, Inc
$49
Merck Sharp & Dohme LLC
$43
Kowa Pharmaceuticals America, Inc.
$38
HEARTFLOW, INC.
$25
GENZYME CORPORATION
$25
Xeris Pharmaceuticals, Inc.
$20
Phathom Pharmaceuticals, Inc.
$20
Renalytix AI, Inc.
$18
Phadia US Inc.
$16
Novartis Pharmaceuticals Corporation
$15
Top 3 companies account for 35.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,065
GlaxoSmithKline, LLC.
$1,187
Novo Nordisk Inc
$1,162
Lilly USA, LLC
$1,110
Amgen Inc.
$792
Boehringer Ingelheim Pharmaceuticals, Inc.
$658
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$637
ABBVIE INC.
$591
Novartis Pharmaceuticals Corporation
$567
AbbVie Inc.
$563
Abbott Laboratories
$393
Janssen Pharmaceuticals, Inc
$312
PFIZER INC.
$287
Otsuka America Pharmaceutical, Inc.
$246
Amarin Pharma Inc.
$242
Amneal Pharmaceuticals LLC
$203
Bayer Healthcare Pharmaceuticals Inc.
$202
Merck Sharp & Dohme Corporation
$189
SCILEX PHARMACEUTICALS INC.
$185
Esperion Therapeutics, Inc.
$160
Exact Sciences Corporation
$135
Bayer HealthCare Pharmaceuticals Inc.
$118
E.R. Squibb & Sons, L.L.C.
$110
Astellas Pharma US Inc
$108
Ardelyx, Inc.
$104
Boston Scientific Corporation
$97
Lundbeck LLC
$97
SANOFI-AVENTIS U.S. LLC
$84
Corcept Therapeutics
$81
Kowa Pharmaceuticals America, Inc.
$75
Merck Sharp & Dohme LLC
$75
MEDICOMP INC
$56
Biohaven Pharmaceutical Holding Company Ltd.
$56
Allergan Inc.
$41
Ironwood Pharmaceuticals, Inc
$38
Genentech USA, Inc.
$36
Shield Therapeutics Inc
$35
Phadia US Inc.
$34
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$28
HEARTFLOW, INC.
$25
GENZYME CORPORATION
$25
Metacel Pharmaceuticals LLC
$24
Scilex Pharmaceuticals Inc.
$24
Xeris Pharmaceuticals, Inc.
$20
Phathom Pharmaceuticals, Inc.
$20
Edwards Lifesciences Corporation
$19
HeartFlow, Inc.
$19
Renalytix AI, Inc.
$18
Horizon Therapeutics plc
$18
Takeda Pharmaceuticals U.S.A., Inc.
$15
Althera Pharmaceuticals LLC
$10
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · BAQSIMI · BASAGLAR · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CERDELGA · COMIRNATY · CREON · Cologuard Collection Kit · ELIQUIS · ELYXYB · ELYXYB - CELECOXIB · EMGALITY · ENTRESTO · EVENITY · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FASENRA · FFRct · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · IBSRELA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LYVISPAH · LifeVest · Linzess · Livalo · MOUNJARO · NEXLETOL · NUCALA · NURTEC ODT · Otezla · Ozempic · Ozobax · PAXLOVID · PENNSAID · PRADAXA · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · RESONATE · REXULTI · RYBELSUS · Repatha · Roszet · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STIOLTO · STIOLTO RESPIMAT · SYNJARDY · TELEPATCH CARDIAC MONITOR · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · UNITHROID · VERQUVO · VIBERZI · VOQUEZNA · VPRIV · VRAYLAR · Vascepa · Veozah · WATCHMAN · Wegovy · XARELTO · XIFAXAN · Xofluza · ZENPEP · ZORYVE · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in NY.
Geographic Context
Internal medicine physicians within 10 mi
10,166
Per 100K population
732.3
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Varghese is a clinical cardiology specialist, with above-average Medicare volume (top 9% in NY), with low-engagement industry engagement in the top 7% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Varghese experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Varghese performed 892 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Varghese receive payments from pharmaceutical companies?
Yes. Dr. Varghese received a total of $13,392 from 51 companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Varghese's costs compare to other internal medicine physicians in New Hyde Park?
Dr. Varghese's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Varghese) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in New Hyde Park
Browse internal medicine physicians in New Hyde Park ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology